<DOC>
	<DOCNO>NCT01625338</DOCNO>
	<brief_summary>This study evaluate efficacy , safety , tolerability sofosbuvir ( SOF ; GS-7977 ) combination ribavirin ( RBV ) without pegylated interferon ( Peg-IFN ) adult chronic hepatitis C virus ( HCV ) infection participate prior Gilead HCV study achieve sustained virologic response ( SVR ) .</brief_summary>
	<brief_title>Open-Label Study Sofusbuvir+Ribavirin With Without Peginterferon Alfa-2a Subjects With Chronic HCV Infection Who Participated Prior Gilead HCV Studies</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Infection HCV Must participate prior Gilead HCV study Use highly effective contraception method female childbearing potential sexually active male Eligible patient include follow receive placebo PegIFN+RBV control arm previously participate Gileadsponsored HCV study attain sustain virologic response 24 week discontinuation therapy ( SVR24 ) regimen contain : Sofosbuvir+RBV PegIFN and/or RBV combination one Gilead investigational directacting agent Pregnant nurse female male pregnant female partner Current prior history clinical hepatic decompensation Infection hepatitis B virus ( HBV ) human immunodeficiency virus ( HIV ) Chronic use systemically administer immunosuppressive agent Active drug abuse Use prohibit concomitant medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>HCV genotype 2 ( GT-2 )</keyword>
	<keyword>HCV genotype 3 ( GT-3 )</keyword>
	<keyword>HCV</keyword>
	<keyword>Sustained Virologic Response</keyword>
	<keyword>Direct Acting Antiviral</keyword>
	<keyword>Combination Therapy</keyword>
	<keyword>GS-7977</keyword>
	<keyword>Ribavirin</keyword>
	<keyword>Open Label</keyword>
</DOC>